{"title": "Combination immunotherapy could stop liver cancer growth", "title_detail": {"type": "text/plain", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/immune_system.xml", "value": "Combination immunotherapy could stop liver cancer growth"}, "links": [{"rel": "alternate", "type": "text/html", "href": "https://www.sciencedaily.com/releases/2019/03/190313140610.htm"}], "link": "https://www.sciencedaily.com/releases/2019/03/190313140610.htm", "summary": "New preclinical data offers proof-of-principle for a combination immunotherapy that suppresses tumor growth in the liver. Current therapies for liver cancer are largely ineffective, resulting in poor outcomes.", "summary_detail": {"type": "text/html", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/immune_system.xml", "value": "New preclinical data offers proof-of-principle for a combination immunotherapy that suppresses tumor growth in the liver. Current therapies for liver cancer are largely ineffective, resulting in poor outcomes."}, "published": "Wed, 13 Mar 2019 14:06:10 EDT", "published_parsed": [2019, 3, 13, 18, 6, 10, 2, 72, 0], "id": "https://www.sciencedaily.com/releases/2019/03/190313140610.htm", "guidislink": false}